Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
TERIPARATIDE 0.25 mg  Injection bulk supplier for pharma manufacturers

Teriparatide 0.25 mg Injection 0.25 mg/ ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 0.25 mg/ ml

Reference Brands: -

Category: Osteoporosis

It is used to treat bone loss (osteoporosis) in men and postmenopausal women at high risk of fracture. It is a synthetic form of the parathyroid hormone naturally produced in the body. This Injection is the only drug that works on bone formation, while the other drugs work on bone resorption.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Teriparatide 0.25 mg Injection? List it or send an offer →

Product Description:

Used in the treatment of bone loss (osteoporosis) in men and postmenopausal women.

Teriparatide is a medication used in the treatment and management of osteoporosis, belonging to the anabolic class of osteoporosis therapies. It is a recombinant form of the first 34 amino acids of human parathyroid hormone (PTH) and functions as a potent osteoanabolic agent. Unlike continuous high levels of PTH, which can lead to bone resorption, intermittent low-dose administration of teriparatide stimulates bone formation more than resorption, increasing bone density and strength.

 

Also known as: teriparatida (Spanish, Portuguese, Indonesian), tériparatide (French), Teriparatid (German), teriparatide (Italian), تيريباراتيد (Arabic), 特立帕肽 (Chinese), テリパラチド (Japanese).

Teriparatide 0.25 mg Injection — third party manufacturing & bulk supply

Teriparatide 0.25 mg Injection 0.25 mg/ ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Teriparatide 0.25 mg Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Teriparatide 0.25 mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Teriparatide 0.25 mg Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Teriparatide is used to treat osteoporosis in patients at high risk of fractures by stimulating new bone growth and increasing bone density.

Teriparatide is a recombinant peptide, the first 34 amino acids of human parathyroid hormone (PTH 1-34), produced using recombinant DNA technology.

The main trade names are Forteo (USA) and Forsteo (EU/UK).

Teriparatide is manufactured by Eli Lilly and Company.

The generic name is teriparatide.

Brand names are Forteo (USA), Terrosa (EU) and Forsteo (EU/UK).

Teriparatide injections are manufactured in GMP-certified facilities by Eli Lilly in the USA and distributed internationally under regional brand names.

La teriparatida es un fragmento activo de la hormona paratiroidea humana obtenido por tecnología recombinante, que estimula la formación de hueso y está indicado para tratar la osteoporosis en mujeres posmenopáusicas y en hombres con alto riesgo de fractura, así como la osteoporosis inducida por glucocorticoides. Se utiliza con receta y bajo la supervisión de un especialista. PharmaTradz apoya a importadores, distribuidores y hospitales con licencia en la compra de teriparatida inyectable a fabricantes con certificación GMP.

A teriparatida é um fragmento ativo do hormônio paratireoidiano humano obtido por tecnologia recombinante, que estimula a formação óssea e é indicada no tratamento da osteoporose em mulheres na pós-menopausa e em homens com alto risco de fratura, além da osteoporose induzida por glicocorticoides. É usada com prescrição e sob supervisão de um especialista. A PharmaTradz apoia importadores, distribuidores e hospitais licenciados na compra de teriparatida injetável de fabricantes com certificação GMP.

Le tériparatide est un fragment actif de l'hormone parathyroïdienne humaine produit par technologie recombinante, qui stimule la formation osseuse ; il est indiqué dans le traitement de l'ostéoporose chez la femme ménopausée et chez l'homme à risque élevé de fracture, ainsi que de l'ostéoporose cortisonique. Il est prescrit sur ordonnance et utilisé sous la surveillance d'un spécialiste. PharmaTradz accompagne les importateurs, distributeurs et hôpitaux agréés dans l'achat de tériparatide injectable auprès de fabricants certifiés BPF (GMP).

Related Products

Teriparatide Injection

Strength:
20 mcg/0.5 mL

Form: injection (prefilled syringe)

Reference Brands: Forteo (USA/EU)

View Details
Leflunomide

Strength:
10 mg

Form: Tablets

Reference Brands: Arava (US/EU)

View Details
Calcium + Vitamin D3 Tablet

Strength:
multiple

Form: Tablets

Reference Brands: -

View Details
Calcium Citrate / Alfacalcidol / Zinc Sulphate Tablet

Strength:
1000mg + 0.25mcg + 7.5mg

Form: Tablets

Reference Brands: -

View Details
Abaloparatide

Strength:
80 mcg

Form: injection (prefilled syringe)

Reference Brands: Tymlos (USA), Eladynos (EU)

View Details
Strontium Ranelate

Strength:
2 g

Form: Sachet

Reference Brands: Osseor (EU/UK)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us